GÜNDÜZ, F. Et Al. 2022. Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy. JOURNAL OF HEPATOLOGY , vol.77 .

GÜNDÜZ, F., DURAK, S., ÜNSAL, Y., DEMİR, M., Ellik, Z. M., YILDIRIM, A. E., ... Mehdiyev, S.(2022). Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy. JOURNAL OF HEPATOLOGY , vol.77.

GÜNDÜZ, FEYZA Et Al. "Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy," JOURNAL OF HEPATOLOGY , vol.77, 2022

GÜNDÜZ, FEYZA Et Al. "Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy." JOURNAL OF HEPATOLOGY , vol.77, 2022

GÜNDÜZ, F. Et Al. (2022) . "Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy." JOURNAL OF HEPATOLOGY , vol.77.

@article{article, author={FEYZA GÜNDÜZ Et Al. }, title={Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy}, journal={JOURNAL OF HEPATOLOGY}, year=2022}